Public-registry site landscape for NCT03006770, a Critical Limb Ischemia (CLI) study sponsored by Pluristem Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03006770 (registry record) |
| Sponsor | Pluristem Ltd. |
| Condition(s) | Critical Limb Ischemia (CLI) |
| Phase | PHASE3 |
| Listed sites | 57 |
| Site countries | United States, Bulgaria, Czechia, Germany, Hungary, Israel, North Macedonia, Poland, United Kingdom |
Eichor generates a preliminary site-risk snapshot for NCT03006770 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →